HUTCHMED (China) Limited (HKG:0013)
Hong Kong · Delayed Price · Currency is HKD 21.98
-0.84 (-3.68%)
Nov 21, 2025, 11:59 AM HKT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of 19.43 billion as of November 20, 2025. Its market cap has decreased by -17.75% in one year.
Market Cap
19.43B
Enterprise Value
10.12B
Revenue
4.73B
Ranking
n/a
PE Ratio
5.30
Stock Price
21.98
Market Cap Chart
Since May 19, 2006, HUTCHMED (China)'s market cap has increased from 1.87B to 19.43B, an increase of 941.16%. That is a compound annual growth rate of 12.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 19.09B | -2.27% |
| Dec 31, 2024 | 19.53B | -18.73% |
| Dec 29, 2023 | 24.03B | 14.66% |
| Dec 30, 2022 | 20.96B | -56.27% |
| Dec 31, 2021 | 47.93B | 35.91% |
| Dec 31, 2020 | 35.26B | 35.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 323.98B |
| Hansoh Pharmaceutical Group Company | 236.23B |
| JD Health International | 222.18B |
| Innovent Biologics | 154.92B |
| WuXi Biologics | 130.87B |
| Sino Biopharmaceutical | 124.78B |
| Akeso | 107.04B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.44B |